Lotus Ventures (the “Company”) (CSE:J) is approaching completion of its initial 22,500 square feet facility and anticipates submission of its evidence package in November. Design work and building permit drawings for the expansion of the facility by an additional 28,000 – 30,000 square feet is almost complete. The company will provide an update on the expansion budget, estimated capacity and timeline shortly after permit drawings are complete.

Lotus Ventures has retained IF Communications for assistance in the company’s packaging and branding of Lotus’ strains. The company executives and production staff including Head Grower and First Grower identified the groups dedication to reliable production of premium cannabis products. The company is well aware of the North Okanagan’s tradition of producing top-quality medical and recreational marijuana, and in a wide variety of specialized strains.


The Lotus brand approach will express the enhancement of plant health and growing conditions through authentic cultivation processes, and the best technology on environmental and sanitation controls. These technologies also enable low production costs for a premium product.

Further to the news release of October 15, 2018, the company has closed a third tranche of its non-brokered private placement financing by issuance of 2,800,000 units at a price of $0.25 per unit for gross proceeds of $700,000. Each unit consists of one common share and one transferrable share purchase warrant, each warrant exercisable to purchase one common share at $0.30 per share for five years. Securities issued pursuant to the financing are subject to a four-month hold period under applicable Canadian securities law. Total proceeds from the placement, announced Sept. 11, 2018, was an aggregate of $2,815,000 and 11,260,000 units issued. The proceeds from the Offering will be used for working capital and general corporate purposes.

ON BEHALF OF THE BOARD

Lotus Ventures Inc.

“Dale McClanaghan”
Dale McClanaghan, President and CEO

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844 or Daniel McRobert, Communications danielmcrobertt@gmail.com (604) 842-4625

Forward-Looking Information

This news release may contain certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projection contained in the forward-looking information throughout this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures (the “Company”) (CSE:J) for an Investor Presentation.

Source: www.lotusventures.ca

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less